ES8801677A1 - Procedimiento para preparar un conjugado de substancia activa de anclaje a membrana. - Google Patents

Procedimiento para preparar un conjugado de substancia activa de anclaje a membrana.

Info

Publication number
ES8801677A1
ES8801677A1 ES556417A ES556417A ES8801677A1 ES 8801677 A1 ES8801677 A1 ES 8801677A1 ES 556417 A ES556417 A ES 556417A ES 556417 A ES556417 A ES 556417A ES 8801677 A1 ES8801677 A1 ES 8801677A1
Authority
ES
Spain
Prior art keywords
active ingredient
anchoring membrane
alkyl
different
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556417A
Other languages
English (en)
Other versions
ES556417A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8801677A1 publication Critical patent/ES8801677A1/es
Publication of ES556417A0 publication Critical patent/ES556417A0/es
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN CONJUGADO DE SUSTANCIA ACTIVA DE ANCLAJE A MEMBRANA, DE FORMULAS (I, II, III). COMPRENDE LAS OPERACIONES DE ELEGIR COMO SUSTANCIA ACTIVA UN PEPTIDO PROTEGIDO CON GRUPOS PROTECTORES EN LAS FUNCIONES EN LAS QUE NO DEBE TENER LUGAR NINGUN TIPO DE REACCION; DE UNIR DICHO PEPTIDO PRIMERAMENTE POR COPULACION A UN SOPORTE POLIMERO Y LUEGO SE UNE COVALENTEMENTE, A TRAVES DE N-TERMINALES O FUNCIONES LATERALES, CON UN COMPUESTO DE ANCLAJE A MEMBRANA; Y DE DISOCIAR LOS GRUPOS PROTECTORES Y SEPARAR LA UNION DE PEPTIDO-SOPORTE, PARA OBTENER EL PEPTIDO DE ANCLAJE A MEMBRANA. DE APLICACION EN LA PREPARACION DE ANTICUERPOS CONVENCIONALES Y MONOCLONALES IN VIVO E IN VITRO.
ES556417A 1985-06-24 1986-06-23 Procedimiento para preparar un conjugado de substancia activa de anclaje a membrana. Expired ES8801677A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3522512 1985-06-24
DE19853546150 DE3546150A1 (de) 1985-06-24 1985-12-27 Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung

Publications (2)

Publication Number Publication Date
ES8801677A1 true ES8801677A1 (es) 1988-02-16
ES556417A0 ES556417A0 (es) 1988-02-16

Family

ID=25833375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556417A Expired ES8801677A1 (es) 1985-06-24 1986-06-23 Procedimiento para preparar un conjugado de substancia activa de anclaje a membrana.

Country Status (12)

Country Link
EP (1) EP0210412B1 (es)
JP (1) JP2594259B2 (es)
KR (1) KR930008091B1 (es)
AT (1) ATE131491T1 (es)
AU (1) AU611385B2 (es)
CA (1) CA1340656C (es)
DE (2) DE3546150A1 (es)
DK (1) DK172399B1 (es)
ES (1) ES8801677A1 (es)
FI (1) FI94419C (es)
NO (1) NO174207C (es)
PT (1) PT82826B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937412A1 (de) * 1989-11-10 1991-05-16 Hoechst Ag Synthetische vakzine zur spezifischen induktion zytotoxischer t-lymphozyten
DE3813821A1 (de) * 1988-04-22 1989-11-02 Hoechst Ag Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
AU619443B2 (en) * 1986-04-21 1992-01-30 Bioenterprises Pty. Ltd. Immunopotentiation
JPS63107742A (ja) * 1986-05-20 1988-05-12 Wako Pure Chem Ind Ltd 新規な機能性リポソ−ム及びその製造法
DE3700173A1 (de) * 1987-01-05 1988-07-14 Hoechst Ag Verfahren zur herstellung von lipophilen aminosaeurederivaten sowie lipophile aminosaeurederivate
US5976839A (en) * 1987-03-13 1999-11-02 Bioenterprises Pty Limited Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
EP0485563B1 (de) * 1990-05-30 1994-12-21 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Polyethersubstituierte tumormittel
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
EP0604945A1 (en) * 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
DE4325317C2 (de) * 1993-07-29 1998-05-20 Univ Dresden Tech Verfahren zur radioaktiven Markierung von Immunglobulinen
DE4329309A1 (de) * 1993-08-31 1995-03-09 Rapp Polymere Gmbh Lipopeptid-Verbindungen
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
FR2727117A1 (fr) * 1994-11-18 1996-05-24 Geffard Michel Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun
US6117940A (en) * 1997-10-17 2000-09-12 Mjalli; Adnan M. M. Amino-ketone solid support templates
IL131266A0 (en) * 1999-08-05 2001-01-28 N S T Neurosurvival Technologi Peptides and pharmaceutical compositions comprising same
IL125908A (en) 1998-08-24 2005-05-17 Nst Neurosurvival Technologies Peptides and pharmaceutical compositions comprising same
GB9915074D0 (en) * 1999-06-28 1999-08-25 Cortecs Plc Ligand-binding composition
DE102009034779A1 (de) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
EA031379B1 (ru) * 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
DE102011018499A1 (de) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut
WO2014055754A1 (en) * 2012-10-05 2014-04-10 The University Of Kansas Conformationally-constrained kinked endosomal-disrupting peptides
US10766928B2 (en) 2012-10-05 2020-09-08 The University Of Kansas Targeted conformationally-constrained kinked endosomal disrupting peptides
WO2015163488A1 (en) * 2014-04-25 2015-10-29 Ajinomoto Co., Inc. Immunostimulating agent
DE102016005550B4 (de) 2016-05-09 2024-09-26 Hans-Georg Rammensee Adjuvans zur lnduzierung einer zellulären lmmunantwort
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000330B1 (de) * 1977-06-20 1981-08-05 Ciba-Geigy Ag Lipopeptide, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Präparate
US4125569A (en) 1977-08-25 1978-11-14 Mobil Oil Corporation Process for increasing hydrogenation rate of polymerized n-alphaolefins
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate

Also Published As

Publication number Publication date
DK294086A (da) 1986-12-25
FI862631A0 (fi) 1986-06-19
NO862511D0 (no) 1986-06-23
KR870000359A (ko) 1987-02-18
DE3650448D1 (de) 1996-01-25
AU611385B2 (en) 1991-06-13
NO174207C (no) 1994-03-30
EP0210412A2 (de) 1987-02-04
DK172399B1 (da) 1998-05-18
KR930008091B1 (en) 1993-08-25
JP2594259B2 (ja) 1997-03-26
EP0210412A3 (en) 1990-02-07
FI862631A (fi) 1986-12-25
PT82826B (pt) 1989-01-17
JPS6263600A (ja) 1987-03-20
FI94419C (fi) 1995-09-11
ES556417A0 (es) 1988-02-16
PT82826A (de) 1986-07-01
ATE131491T1 (de) 1995-12-15
EP0210412B1 (de) 1995-12-13
NO174207B (no) 1993-12-20
CA1340656C (en) 1999-07-20
DE3546150A1 (de) 1987-01-22
DK294086D0 (da) 1986-06-23
NO862511L (no) 1986-12-29
AU5894386A (en) 1987-01-08
FI94419B (fi) 1995-05-31

Similar Documents

Publication Publication Date Title
ES8801677A1 (es) Procedimiento para preparar un conjugado de substancia activa de anclaje a membrana.
PT79735A (de) 11beta-aryl-estradiene deren herstellung und diese enthaltende pharmazeutische praeparate
FI905575A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
NZ217844A (en) A sustained release pharmaceutical composition containing silicone elastomer and an albumin
ES8707520A1 (es) Un procedimiento para preparar derivados de acido piridoncarboxilico
KR890014098A (ko) 카테콜 아민 유도체를 함유하여 이루어지는 중추성 신경퇴행성 질환의 진행방지 및 치료제
ES452226A1 (es) Procedimiento para la preparacion de delta15-esteroides.
KR940021059A (ko) 지질 대사 개선제
GB2192134A (en) Transdermal delivery of drugs
ES539683A0 (es) Procedimiento para la preparacion de 6,6-etilen-15,16-meti- len-3-oxo-17&-pregn-4-en-21,17-carbolactonas
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IE42168L (en) 1-alpha-hydroxy and alkanoyloxy-steroids
DE69624121D1 (de) Membranen possierende second messengers
SE8200757L (sv) Biologiskt aktiva peptider
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
ES2016931B3 (es) Procedimiento de preparación de nuevas amidas alifáticas y cicloalifáticas de piridilalquilaminas o de sus derivados N-óxidos.
BR9610229A (pt) Oxidos de polihidroxialquilamidamina
ES8402845A1 (es) "procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas"
DK101085D0 (da) Carbacycliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20061106